← Every applicant
Takeda Pharms USA FDA Approvals
7 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| ORZEYFULNew drugAug 5, 2026TABLET, ORAL |
| ENTYVIONew drugApr 18, 2024INJECTABLE, INTRAVENOUS |
| EOHILIANew drugFeb 9, 2024SUSPENSION, ORAL |
| FRUZAQLANew drugNov 8, 2023CAPSULE, ORAL |
| ENTYVIONew drugSep 27, 2023INJECTABLE, INTRAVENOUS |
| LIVTENCITYNew drugNov 23, 2021TABLET, ORAL |
| EXKIVITYNew drugSep 15, 2021CAPSULE, ORAL |